CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+7.7%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.72B
AUM Growth
+$403M
(+7.6%)
Cap. Flow
+$55.5M
Cap. Flow
% of AUM
0.97%
Top 10 Holdings %
Top 10 Hldgs %
15.98%
Holding
775
New
66
Increased
305
Reduced
281
Closed
46
Top Buys
| 1 |
Microsoft
MSFT
|
+$45.2M |
| 2 |
Procter & Gamble
PG
|
+$30.3M |
| 3 |
Baidu
BIDU
|
+$29.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$24.2M |
| 5 |
Eli Lilly
LLY
|
+$23M |
Top Sells
| 1 |
GE Aerospace
GE
|
+$29.4M |
| 2 |
SPLS
Staples Inc
SPLS
|
+$26.4M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$25.3M |
| 4 |
Motorola Solutions
MSI
|
+$24.5M |
| 5 |
Amgen
AMGN
|
+$23.9M |
Sector Composition
| 1 | Healthcare | 27.14% |
| 2 | Technology | 13.78% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 9.45% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
S
326
DELISTED
Sprint Corporation
S
| $3.58M | 0.06% |
460,458
+177,855
| +63% | +$1.38M |
|
327
Marriott International Class A Common Stock
MAR
$71.7B
| $3.57M | 0.06% |
32,337
-450
| -1% | -$49.6K |
|
328
Sysco
SYY
$38.7B
| $3.56M | 0.06% |
65,999
+3,645
| +6% | +$197K |
|
329
Supernus Pharmaceuticals
SUPN
$2.58B
| $3.56M | 0.06% |
89,000
+18,000
| +25% | +$720K |
|
330
Ovintiv
OVV
$10.7B
| $3.54M | 0.06% |
60,238
-893
| -1% | -$52.4K |
|
331
Labcorp
LH
$23.1B
| $3.53M | 0.06% |
27,242
-2,612
| -9% | -$339K |
|
|
EGRX
332
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.52M | 0.06% |
59,000
+11,000
| +23% | +$656K |
|
333
Host Hotels & Resorts
HST
$12B
| $3.49M | 0.06% |
188,761
-187,638
| -50% | -$3.47M |
|
|
CALA
334
DELISTED
Calithera Biosciences, Inc
CALA
| $3.47M | 0.06% |
11,000
-2,405
| -18% | -$758K |
|
335
CSX Corp
CSX
$60B
| $3.46M | 0.06% |
191,319
+3,351
| +2% | +$60.6K |
|
336
Edwards Lifesciences
EW
$46.9B
| $3.44M | 0.06% |
94,521
+327
| +0.3% | +$11.9K |
|
337
Charles Schwab
SCHW
$170B
| $3.39M | 0.06% |
77,596
+3,062
| +4% | +$134K |
|
338
BCE
BCE
$22.6B
| $3.39M | 0.06% |
72,519
+3,140
| +5% | +$147K |
|
339
HP
HPQ
$27.1B
| $3.38M | 0.06% |
169,505
-15,585
| -8% | -$311K |
|
|
SAGE
340
DELISTED
Sage Therapeutics
SAGE
| $3.36M | 0.06% |
54,000
-9,000
| -14% | -$561K |
|
|
LUMO
341
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $3.34M | 0.06% |
36,444
+28,111
| +337% | +$2.58M |
|
342
Brunswick
BC
$4.27B
| $3.32M | 0.06% |
+59,355
| New | +$3.32M |
|
343
Scotiabank
BNS
$79.3B
| $3.32M | 0.06% |
51,788
-8,306
| -14% | -$533K |
|
344
Southern Company
SO
$100B
| $3.32M | 0.06% |
67,451
+1,586
| +2% | +$77.9K |
|
345
Truist Financial
TFC
$58.4B
| $3.31M | 0.06% |
70,605
-606
| -0.9% | -$28.4K |
|
346
Dominion Energy
D
$50.2B
| $3.27M | 0.06% |
42,554
+1,512
| +4% | +$116K |
|
347
Zoetis
ZTS
$66.4B
| $3.26M | 0.06% |
51,163
+3,943
| +8% | +$251K |
|
348
Walmart
WMT
$816B
| $3.22M | 0.06% |
123,741
+16,872
| +16% | +$439K |
|
349
CME Group
CME
$94.3B
| $3.22M | 0.06% |
23,717
+1,107
| +5% | +$150K |
|
350
Rigel Pharmaceuticals
RIGL
$644M
| $3.21M | 0.06% |
126,500
+8,500
| +7% | +$216K |
|